Navigation Links
Two-time Defending NASCAR Sprint Cup Series Champion Jimmie Johnson Joins the Team at CORD:USE Cord Blood Bank to Help Win the Race for Life
Date:2/12/2008

DAYTONA BEACH, Fla., Feb. 12 /PRNewswire/ -- CORD:USE Cord Blood Bank is proud to announce that two-time defending NASCAR Sprint Cup Series Champion Jimmie Johnson has joined its team. "We're honored to have this NASCAR superstar and terrific person on our team," states Dr. Edward Guindi, President and CEO of CORD:USE. Jimmie Johnson joins CORD:USE as a spokesperson to participate in its "Help Win the Race for Life(TM)" campaign.

"I'm excited about telling people the benefits of umbilical cord blood donation and cord blood stem cell treatments for people in life-or-death situations," says Johnson.

"The fact that umbilical cord blood, which is normally just thrown out after a baby's born, could be donated and used to save someone's life - that just blows me away. We've got over 75 million good-hearted NASCAR fans out there, and together we can make a real difference in CORD:USE's efforts to save lives. I support this with my whole heart, and you better believe when I'm a parent some day, it's something that I'm going to participate in first hand."

Jimmie Johnson joins other NASCAR greats Rusty Wallace and Michael Waltrip, who have played an active role in increasing public awareness of cord blood donation and the dozens of current applications utilizing cord blood stem cells in transplantation.

"They call it The Race for Life, and it's a race team I'm excited to be a part of. CORD:USE's team is made up of many of the top physicians and scientists in this important medical field, which is saving thousands of lives. You know me, every race I'm in, I want to win - and I'm especially determined to win this one," says Johnson.

Cord blood stem cells have already been used to treat more than 10,000 patients, saving thousands of people who would otherwise not have had a chance of survival. There are currently more than 70 different diseases that have been successfully treated utilizing cord blood stem cells.

About CORD:USE Cor
'/>"/>

SOURCE CORD:USE Cord Blood Bank
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Good Neighbor Pharmacy Joins with Diversified Racing Solutions to Enter NASCAR Nationwide Series in 2008
2. Hyperion Therapeutics Secures $40 Million In Series B Round
3. Enobia Pharma Raises $40.1 Million Series B Financing
4. OpGen Announces $23.6 Million Series A Financing
5. Amyris Biotechnologies Announces $70 Million Series B Round
6. Apollo Endosurgery, Inc. Secures $11.5 Million in Series A Financing.
7. Response Genetics CEO to Discuss Advances in Optimizing Therapy through Pharmacogenomics as Part of a Series of Presentations at AACR-NCI-EORTC International Conference
8. VisEn Medical Raises $7 Million in Series B Financing
9. Nikon Unveils the Eclipse Ti Inverted Microscope Series at The Society for Neroscience Annual Meeting
10. BioVex Closes Second Round of Series E Financing
11. Antibody Engineering Company f-star Raises EUR 3.0 Million in a Second Closing of its Series A Financing Round From Novo A/S
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... , June 30, 2015 /PRNewswire/ - Resverlogix Corp. ... common shares of Resverlogix have approved the resolutions ... Capital Limited of 5,600,000 units at a price ... each unit being comprised of one common share ... proceeds of approximately CAD$15 million; and (ii) the ...
(Date:6/30/2015)... NEW YORK , June 30, 2015  Today, Americord ... the U.S., announced Andrew Horne , a partner at ... Advisory Board. Logo - http://photos.prnewswire.com/prnh/20150630/226958LOGO   ... appointment to Americord,s Advisory Board," says Martin Smithmyer , ... experience in his legal career that will assist Americord,s growth ...
(Date:6/30/2015)... ... 30, 2015 , ... The maximum number of shares proposed to be purchased ... shares of unvested restricted stock). On June 29, 2015, the last trading day prior ... reported on the OTCBB was $2.29 per share. , The tender offer will expire ...
(Date:6/30/2015)... 2015 /PRNewswire/ - RepliCel Life Sciences Inc. (OTCQB: ... company focused on the development of autologous cell ... Phase 1/2 clinical trial of RCT-01, being tested ... has been enrolled and their tissue biopsy sent ... is comprised of non-bulbar dermal sheath (NBDS) cells ...
Breaking Biology Technology:Resverlogix Corp. Shareholders Approve Matters Relating to Licensing and Equity Arrangement 2Resverlogix Corp. Shareholders Approve Matters Relating to Licensing and Equity Arrangement 3Americord Registry Announces Andrew Horne as Advisory Board Member 2Cryo-Cell Commences Tender Offer to Purchase its Common Stock, Up to 750,000 Shares at $3.25 per Share 2Cryo-Cell Commences Tender Offer to Purchase its Common Stock, Up to 750,000 Shares at $3.25 per Share 3RepliCel Life Sciences Enrolls First Participant in Phase 1/2 Clinical Trial of RCT-01 for Chronic Achilles Tendinosis 2RepliCel Life Sciences Enrolls First Participant in Phase 1/2 Clinical Trial of RCT-01 for Chronic Achilles Tendinosis 3RepliCel Life Sciences Enrolls First Participant in Phase 1/2 Clinical Trial of RCT-01 for Chronic Achilles Tendinosis 4
... Biovista Inc. today,announced that BVA-101, its drug targeting ... the MOG-induced Experimental Allergic,Encephalomyelitis (EAE) murine model of ... MS and is aimed at neuroprotection, was shown ... toxic effects in this well,established model of MS. ...
... announced that Merck & Co. Inc. has chosen ... collaboration agreement announced in June 2008 to apply ... novel small molecule leads against several drug targets.By ... a new multi-million member proprietary library of small ...
... manager of Xmark Opportunity Fund, L.P. and Xmark Opportunity Fund, Ltd., sent the following letter to the Board of Directors of Icagen, Inc. ... XMARK OPPORTUNITY PARTNERS, LLC, ... 90 Grove Street, ... 201, ...
Cached Biology Technology:Biovista Inc. Announces Positive Efficacy Results in a Pre-Clinical Trial of its BVA-101 Repositioned Drug for Multiple Sclerosis 2Nuevolution Announces Progress in Its Collaboration With Merck & Co. Inc. 2Xmark Requests That Icagen Oust Its CEO and Pursue Strategic Alternatives, and Calls on Board Members to Resign 2
(Date:6/23/2015)... June 23, 2015  Crossmatch™, a leading ... today announced enhanced functionality of its DigitalPersona ... The enhancements build on the native flexibility ... Altus platform and provide expanded mobile credential ... In today,s environment of increasing cyber-attacks and ...
(Date:6/17/2015)... , and HILDEN, Germany , June 17, ... ; Frankfurt Prime Standard: QIA) today launched new Investigator ® ... forensic laboratories in the United States . ... simultaneously analyze multiple key genomic markers (short tandem repeats or ... Quality Sensor to evaluate the quality of DNA in each ...
(Date:6/16/2015)...  With the increasing number and severity of data ... The recent compromise of Federal employee data from ... within government agencies. HYPR Corp. announced today ... authenticator, has been submitted for testing and approval of ... for tamper proofing. The proliferation of ...
Breaking Biology News(10 mins):Crossmatch Releases Enhanced DigitalPersona Altus Advanced Authentication Functionality 2QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 2QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 3QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 4QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 5Government Ready Biometric Security Approaching as HYPR Corp. Files FIPS 140-2 Level 3 Validation for Its Proprietary Biometric Token 2Government Ready Biometric Security Approaching as HYPR Corp. Files FIPS 140-2 Level 3 Validation for Its Proprietary Biometric Token 3
... Cruz Mountains two closely related species of mice share a ... lives. The California mouse ( Peromyscus californicus ) is characterized ... maniculatus ) is sexually promiscuous. Researchers at the University ... behavior impact the bacteria hosted by each species as well ...
... trials can be time-consuming, expensive and intrusive, but they ... Space Institute in Tullahoma have developed an invention that ... the virtual world. Called "digital Eye Bank," the ... eyes for researchers to use when testing their inventions. ...
... federal research effort to evaluate freshwater sustainability across the ... can be done to make the best use of ... the effects of climate change over the next 10 ... of Georgia are also part of the project. ...
Cached Biology News:Monogamy and the immune system 2Monogamy and the immune system 3Monogamy and the immune system 4Monogamy and the immune system 5University of Tennessee Space Institute researchers make clinical trials a virtual reality 2NC State leads national effort to evaluate fresh water sustainability in the southern US 2
Mouse monoclonal [3F8 ] to smooth muscle Myosin heavy chain I ( Abpromise for all tested applications). entrezGeneID: 4629 SwissProtID: P35749...
Rabbit polyclonal to pCrosstide (HRP) ( Abpromise for all tested applications)....
IkappaB-alpha (112B2) Mouse mAb...
Human sIL-2R/CD25 ELI-PAIR Kit...
Biology Products: